Takeda Pharmaceuticals International Ag Ireland Branch
SpainAll drugs from this manufacturer
-
It is used as enzyme replacement therapy to treat children and adults with Hunter syndrome (Mucopolysaccharidosis II) when iduronate-2-sulfatase enzyme levels are lower than normal.
Dosage form: solution for infusion, concentrate
Active substance Dosage idursulfase 2 mg -
It is used as part of a comprehensive treatment for attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years (when other treatments have not been effective) and in adults who have had ADHD since childhood. It helps improve attention, concentration, and reduces impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 30.0 mg -
It is used as part of a comprehensive treatment for attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years (when other treatments have not been effective) and in adults who have had ADHD since childhood. It helps improve attention, concentration, and reduces impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 50,0 mg -
It is used as part of a comprehensive treatment program for attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years (when other treatments have not worked) and in adults who have had ADHD since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 70.0 mg -
It is used as part of a comprehensive treatment program for attention deficit hyperactivity disorder (ADHD) in adults who have had this condition since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 30 mg -
It is used as part of a comprehensive treatment program for attention deficit hyperactivity disorder (ADHD) in adults who have had this condition since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 50 mg -
It is used as part of a comprehensive treatment for attention deficit hyperactivity disorder (ADHD) in adults who have had this condition since childhood. It helps improve attention and concentration and reduce impulsivity.
Dosage form: capsules, hard
Active substance Dosage lisdexamfetamine dimesylate 70 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents between 6 and 18 years of age, provided that non-pharmacological treatments such as psychological or behavioral therapy have been attempted first.
Dosage form: capsules, hard modified-release
Active substance Dosage methylphenidate hydrochloride 20 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents between 6 and 18 years of age, provided that non-pharmacological treatments such as psychological or behavioral therapy have been previously tried.
Dosage form: capsules, hard modified-release
Active substance Dosage methylphenidate hydrochloride 29,94 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents between 6 and 18 years of age, provided that non-pharmacological treatments such as psychological or behavioral therapy have been previously tried.
Dosage form: capsules, hard modified-release
Active substance Dosage methylphenidate hydrochloride 40.0 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years, only after non-pharmacological treatments such as psychological or behavioral therapy have been tried.
Dosage form: capsules, hard modified-release
Active substance Dosage methylphenidate hydrochloride 50.0 mg -
It is used to treat the symptoms of hereditary angioedema (HAE) in adults, adolescents, and children over 2 years of age. It helps to reduce swelling, pain, nausea, and diarrhea caused by this disease.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage icatibant 30 mg -
It is used to reduce phosphorus levels in the blood in adults with chronic kidney disease.
Dosage form: tablets, chewable
Active substance Dosage lanthanum carbonate 1908,0 mg -
It is used to reduce phosphorus levels in the blood of adult patients suffering from chronic kidney disease.
Dosage form: powder, oral
Active substance Dosage lanthanum 1000 mg -
It is used to reduce phosphorus levels in the blood in adults with chronic kidney disease.
Dosage form: tablets, chewable
Active substance Dosage lanthanum carbonate 954,0 mg -
It is used to reduce phosphorus levels in the blood in adults with chronic kidney disease.
Dosage form: tablets, chewable
Active substance Dosage lanthanum carbonate 1431,0 mg -
It is used to reduce phosphorus levels in the blood of adult patients suffering from chronic kidney disease.
Dosage form: powder, oral
Active substance Dosage lanthanum 750 mg -
It is used to treat adult patients with colon or rectal cancer (colorectal cancer) that has spread to other parts of the body (metastatic), when other treatments have not worked or are not suitable.
Dosage form: capsules, hard
Active substance Dosage fruquintinib 1 mg -
It is used to treat adult patients with colon or rectal cancer (colorectal cancer) that has spread to other parts of the body, when other treatments have not worked or are not suitable.
Dosage form: capsules, hard
Active substance Dosage fruquintinib 5 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,14 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,28 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,42 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,56 mg -
It is used to treat adults who have received an organ or bone marrow transplant and have a CMV (cytomegalovirus) infection that has not cleared or has recurred after using another antiviral.
Dosage form: tablets, film-coated
Active substance Dosage maribavir 200 mg -
It is used as an anti-inflammatory to treat ulcerative colitis (a disease of the colon and rectum that causes inflammation, redness, and bloody stools) and to prevent the disease from recurring.
Dosage form: tablets, prolonged-release
Active substance Dosage mesalazine 1200 mg -
It is used for the long-term treatment of adult, adolescent, and pediatric patients aged 7 years and older with a confirmed diagnosis of Fabry disease.
Dosage form: solution for infusion, concentrate
Active substance Dosage agalsidase alfa 1 mg -
It is used to treat chronic constipation in adults when laxatives are not sufficient.
Dosage form: tablets, film-coated
Active substance Dosage prucalopride succinate 1 mg -
It is used to treat chronic constipation in adults when laxatives are not sufficient.
Dosage form: tablets, film-coated
Active substance Dosage prucalopride succinate 2 mg -
It is used to treat short bowel syndrome in adults, children, and adolescents (from 4 months of age onwards). This disorder prevents the body from correctly absorbing nutrients and water from the intestine.
Dosage form: powder and solvent for solution for injection
Active substance Dosage teduglutide 5 mg -
It is used to prevent attacks of hereditary angioedema (HAE) in patients from 2 years of age with a body weight of less than 40 kg.
Dosage form: solution for injection
Active substance Dosage lanadelumab 150 mg -
It is used in patients from 2 years of age with hereditary angioedema (HAE) to prevent attacks of this disease.
Dosage form: solution for injection
Active substance Dosage lanadelumab 300 mg -
It is used as long-term enzyme replacement therapy for patients with type 1 Gaucher disease.
Dosage form: powder for solution for infusion
Active substance Dosage velaglucerase alfa 400 U -
It is used to treat patients with essential thrombocythemia, a condition in which the bone marrow produces too many platelets, which can cause circulation and clotting problems.
Dosage form: capsules, hard
Active substance Dosage anagrelide hydrochlorogenide 0,5 mg